Showing results (451-460 of 576) with videos related to

Sort By:
Pageof 58
Journal of Medical Microbiology|October 31, 2025
Multiplex PCR assay for the rapid detection of Klebsiella pneumoniae pathotypesSanika Mahesh Kulkarni, Jobin John Jacob, T Praveen, et al.
The Lancet. Infectious Diseases|October 15, 2020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trialMatteo Bassetti, Roger Echols, Yuko Matsunaga, et al.
Pharmacoeconomics|March 13, 2026
Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing ArthroplastyAn Tran-Duy, Sarah Asbury, Tim Spelman, et al.
Clinical Pharmacokinetics|August 30, 2022
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative ReviewMaría Patricia Hernández-Mitre, Steven Y C Tong, Justin T Denholm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2023
Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical ImplicationsAnna Maria Peri, Kevin O'Callaghan, Nastaran Rafiei, et al.
Implementation Science : IS|March 25, 2016
Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site stepped-wedge randomised trialLisa Hall, Alison Farrington, Brett G Mitchell, et al.
Diagnostic Microbiology and Infectious Disease|June 6, 2025
A global survey of diagnostic practices in prosthetic joint infectionsShradha Subedi, Patrick Na Harris, Paul Chapman, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2021
Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131Minh-Duy Phan, Kate M Peters, Laura Alvarez Fraga, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniaeYu-Wei Lin, Nusaibah Abdul Rahim, Jinxin Zhao, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|August 16, 2013
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II studyJoel M Dulhunty, Jason A Roberts, Joshua S Davis, et al.
Pageof 58